Patient ID
|
CTC detection by one-step microfluidics-based immunomagnetic isolation
|
Ex vivo CTC culture
|
---|
N = 89
|
N = 4
|
N = 85
|
N = 2
|
---|
1
| |
22
| |
2
| |
3
| |
3
| |
81
| |
4
| |
49
| |
5
| |
1
| |
6
| |
28
| |
7
| |
147
| |
8
| |
10
| |
9
| |
2
| |
10
| |
22
| |
11
| |
8
| |
12
| |
1
| |
13
| |
143
| |
14
| |
11
| |
15
| |
39
| |
16
| |
15
| |
17
| |
6
| |
18
| |
22
| |
19
| |
21
| |
20
| |
33
| |
21
| |
4
| |
22
| |
3
| |
23
| |
212
|
Yes
|
24
| |
18
| |
25
| |
9
| |
26
| |
5
| |
27
| |
7
| |
28
| |
4
| |
29
| |
227
| |
30
| |
57
| |
31
|
0
| | |
32
| |
13
| |
33
| |
1
| |
34
| |
25
| |
35
|
0
| | |
36
| |
139
| |
37
| |
12
| |
38
| |
1
| |
39
| |
3
| |
40
| |
8
| |
41
| |
26
| |
42
| |
5
| |
43
| |
6
| |
44
| |
2
| |
45
| |
3
| |
46
| |
130
|
Yesa
|
47
| |
5
| |
48
| |
18
| |
49
| |
16
| |
50
| |
6
| |
51
| |
187
| |
52
| |
5
| |
53
| |
11
| |
54
| |
102
| |
55
| |
177
| |
56
| |
17
| |
57
| |
72
| |
58
| |
11
| |
59
| |
18
| |
60
| |
5
| |
61
| |
9
| |
62
| |
2
| |
63
| |
9
| |
64
| |
8
| |
65
| |
27
| |
66
|
0
| | |
67
| |
65
| |
68
| |
8
| |
69
| |
10
| |
70
| |
15
| |
71
| |
17
| |
72
| |
12
| |
73
|
0
| | |
74
| |
16
| |
75
| |
1
| |
76
| |
6
| |
77
| |
279
| |
78
| |
7
| |
79
| |
3
| |
80
| |
7
| |
81
| |
7
| |
82
| |
1
| |
83
| |
3
| |
84
| |
12
| |
85
| |
28
| |
86
| |
10
| |
87
| |
2
| |
88
| |
9
| |
89
| |
4
| |
- aFrom the female patients with IIA stage, we were able to expand CTCs in cell culture